[HTML][HTML] COVID-19 and Parkinson's disease: shared inflammatory pathways under oxidative stress

ZL Chaudhry, D Klenja, N Janjua, G Cami-Kobeci… - Brain Sciences, 2020 - mdpi.com
The current coronavirus pandemic caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has resulted in a serious global health crisis. It is a major …

[HTML][HTML] ER Stress in COVID-19 and Parkinson's disease: in vitro and in silico evidences

ZL Chaudhry, M Gamal, I Ferhati, M Warda, BY Ahmed - Brain Sciences, 2022 - mdpi.com
The outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) signifies a serious worldwide concern to public health. Both transcriptome …

[HTML][HTML] Parkinson's disease and SARS-CoV-2 infection: particularities of molecular and cellular mechanisms regarding pathogenesis and treatment

A Anghelescu, G Onose, C Popescu, M Băilă, SI Stoica… - Biomedicines, 2022 - mdpi.com
Accumulating data suggest that chronic neuroinflammation-mediated neurodegeneration is
a significant contributing factor for progressive neuronal and glial cell death in age-related …

[HTML][HTML] Cascading from SARS-CoV-2 to parkinson's disease through protein-protein interactions

E Estrada - Viruses, 2021 - mdpi.com
Extensive extrapulmonary damages in a dozen of organs/systems, including the central
nervous system (CNS), are reported in patients of the coronavirus disease 2019 (COVID …

[HTML][HTML] Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19

M Mancini, S Natoli, F Gardoni, M Di Luca… - International Journal of …, 2023 - mdpi.com
Dopamine (DA) is a key neurotransmitter in the basal ganglia, implicated in the control of
movement and motivation. Alteration of DA levels is central in Parkinson's disease (PD), a …

[HTML][HTML] The intersection of Parkinson's disease, viral infections, and COVID-19

B Rosen, A Kurtishi, GR Vazquez-Jimenez… - Molecular …, 2021 - Springer
Abstract The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the
causative agent of human COVID-19, not only causes flu-like symptoms and gut microbiome …

Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases

B Rahmani, E Ghashghayi, M Zendehdel… - Physiology …, 2022 - akjournals.com
Abstract Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In addition to the pulmonary …

[HTML][HTML] Role of SARS-CoV-2 in modifying neurodegenerative processes in Parkinson's disease: a narrative review

JM Morowitz, KB Pogson, DA Roque, FC Church - Brain Sciences, 2022 - mdpi.com
The COVID-19 pandemic, caused by SARS-CoV-2, continues to impact global health
regarding both morbidity and mortality. Although SARS-CoV-2 primarily causes acute …

[HTML][HTML] Systems bioinformatics reveals possible relationship between COVID-19 and the development of neurological diseases and neuropsychiatric disorders

A Onisiforou, GM Spyrou - Viruses, 2022 - mdpi.com
Coronavirus Disease 2019 (COVID-19) is associated with increased incidence of
neurological diseases and neuropsychiatric disorders after infection, but how it contributes …

[HTML][HTML] Systematic review of the common pathophysiological mechanisms in COVID-19 and neurodegeneration: the role of bioactive compounds and natural …

K Choe, HY Park, M Ikram, HJ Lee, TJ Park, R Ullah… - Cells, 2022 - mdpi.com
The novel coronavirus (2019-nCoVCOVID-19) belongs to the Beta coronavirus family, which
contains MERS-CoV (Middle East respiratory syndrome coronavirus) and SARS-CoV …